The oncologic risk of magnetic resonance imaging-targeted and systematic cores in patients treated with radical prostatectomy.
Christopher D GaffneyAmy L TinJonathan FainbergSamson FineGhalib JibaraKarim TouijerJames EasthamPeter ScardinoVincent LaudoneAndrew J VickersBehfar EhdaiePublished in: Cancer (2023)
Using magnetic resonance imaging (MRI) to help diagnose prostate cancer can help identify more high-grade cancers than using a systematic template biopsy alone. However, we do not know if high-grade cancers diagnosed with the help of an MRI are as dangerous to the patient as high-grade cancers diagnosed with a systematic biopsy. We examined all of our patients who had an MRI biopsy and a systematic biopsy and then had their prostates removed to find out if these patients had risk factors and signs of aggressive cancer (cancer that spread outside the prostate or was very high grade). We found that, if there was a difference in grade between the systematic biopsy and the MRI-targeted biopsy, the risk of aggressive cancer was between the two grades.
Keyphrases
- high grade
- magnetic resonance imaging
- prostate cancer
- radical prostatectomy
- contrast enhanced
- ultrasound guided
- low grade
- fine needle aspiration
- papillary thyroid
- diffusion weighted imaging
- risk factors
- squamous cell
- end stage renal disease
- childhood cancer
- newly diagnosed
- magnetic resonance
- chronic kidney disease
- lymph node metastasis
- ejection fraction
- cancer therapy
- peritoneal dialysis
- young adults